XML 17 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Assets    
Cash and cash equivalents $ 464 $ 135
Accounts receivable, net of allowance for doubtful accounts of $17 and $15 as of March 31, 2019 and December 31, 2018, respectively 1,079 1,012
Inventories 98 99
Prepaid expenses and other current assets 137 144
Total current assets 1,778 1,390
Property, plant and equipment, net 1,277 1,288
Operating lease right-of-use assets 497 0
Goodwill 6,605 6,563
Intangible assets, net 1,200 1,207
Investment in equity method investees 454 436
Other assets 126 119
Total assets 11,937 11,003
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 1,029 1,021
Current portion of long-term debt 1,108 464
Current portion of long-term operating lease liabilities 145 0
Total current liabilities 2,282 1,485
Long-term debt 3,131 3,429
Long-term operating lease liabilities 393 0
Other liabilities 713 745
Commitments and contingencies
Redeemable noncontrolling interest 77 77
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2019 and December 31, 2018; 217 shares issued as of both March 31, 2019 and December 31, 2018 2 2
Additional paid-in capital 2,671 2,667
Retained earnings 7,694 7,602
Accumulated other comprehensive loss (55) (59)
Treasury stock, at cost; 83 shares and 82 shares as of March 31, 2019 and December 31, 2018, respectively (5,022) (4,996)
Total Quest Diagnostics stockholders' equity 5,290 5,216
Noncontrolling interests 51 51
Total stockholders' equity 5,341 5,267
Total liabilities and stockholders' equity $ 11,937 $ 11,003